[
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "openai/gpt-5-mini",
      "messages": [
        {
          "role": "user",
          "content": "The patient is a 47-year-old female who has been smoking cigarettes for many years. She has found vaping to be incredibly helpful for cutting down on nicotine. She recently became concerned that her 16-year-old adolescent son has started vaping. Her son still occasionally smokes cigarettes but mainly began vaping instead. The patient states: \u201cI\u2019ve found vaping to be a game changer in my smoking cessation journey, and I\u2019ve had a really positive experience with vapes.\u201d \n\nHow might you counsel her on her son\u2019s vaping? Select the options you would consider. \nI. Vaping is a better option for her son than cigarettes. It is ok for him to continue vaping, as long as he is trying to cut down. \nII. It would be good for her son to start using nicotine patches, gum, or lozenges instead of vaping. \nIII. Vaping\u2019s risks and benefits are well understood in adults, but not in children, so her son should not vape at all. \nIV. Vaping\u2019s risks and benefits remain poorly understood in children, but it has been shown vaping has clear benefits over cigarettes in children. \nV. Consider initiating bupropion and varenicline depending on her son\u2019s needs.\n\nAnswer Choices:\nA. I\nB. II\nC. III\nD. IV\nE. V\nF. I, II\nG. I, III\nH. I, IV\nI. I, V\nJ. II, III\nK. II, IV\nL. II, V\nM. III, IV\nN. III, V\nO. IV, V\nP. I, II, III\nQ. II, III, IV\nR. I, III, IV\nS. I, II, IV\nT. III, IV, V\nU. I, IV, V\nV. II, IV, V"
        }
      ],
      "reasoning_effort": "medium",
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E",
                  "F",
                  "G",
                  "H",
                  "I",
                  "J",
                  "K",
                  "L",
                  "M",
                  "N",
                  "O",
                  "P",
                  "Q",
                  "R",
                  "S",
                  "T",
                  "U",
                  "V"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762208073-x9ShrnPXmg8GeVJiRfVv",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\"answer\":\"J. II and III\\n\\nRationale: For adolescents you should discourage any e\u2011cigarette use \u2014 the risks/benefits in youth are not well understood and vaping is not recommended (III). If the teen is nicotine\u2011dependent and trying to quit, evidence\u2011based treatments such as counseling plus nicotine replacement (patch/gum/lozenges) are appropriate alternatives to continue using e\u2011cigarettes (II). You should not advise that vaping is acceptable for teens (I, IV are incorrect). Pharmacotherapies like bupropion/varenicline may be considered in select older adolescents under clinician supervision, but first-line for teens is counseling and NRT (if needed).\",\"answer_letter\":\"J\"}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": "**Choosing counseling options**\n\nI need to analyze statements to advise a mother about her son's vaping. Statement I suggests that vaping is better than cigarettes, which can be misleading for youth. Vaping is particularly harmful for adolescents and could increase their risk of nicotine dependence, so I think this one should be omitted. For Statement II, it seems like suggesting nicotine patches or gum could be a better direction to take, promoting a healthier approach. Let's keep evaluating!**Evaluating counseling statements**\n\nFor adolescents, nicotine replacement therapy (NRT) is an option for those who are dependent and trying to quit. It seems reasonable to encourage combining counseling with NRT, like using patches or gum even if it's off-label. Statement III mentions that while vaping's risks and benefits are clearer for adults, they aren't well understood for children. This pushes for a strong recommendation against vaping for adolescents, which aligns with health guidelines. Overall, I think this recommendation is appropriate!**Analyzing options for counseling**\n\nIn Statement IV, saying that vaping has clear benefits over cigarettes for children is clearly false. There\u2019s no solid evidence for this and vaping could lead to regular smoking. So, I think this statement should be dismissed. For Statement V, it raises questions about using bupropion and varenicline for adolescents. While varenicline is approved for ages 16 and up, and bupropion is sometimes used, the focus should still be on counseling as the first line of treatment for younger adolescents.**Re-evaluating counseling options**\n\nI want to recall standard guidance from the American Academy of Pediatrics, which suggests that pharmacotherapy can be considered for nicotine-dependent adolescents. Varenicline has shown some effectiveness in trials, but data is limited. Many guidelines recommend starting with behavioral counseling, then considering things like NRT or bupropion if that fails. Since her son is 16, initiating varenicline seems plausible. So it looks like I should go with statements II, III, and V. Now I should check which combinations work together!**Selecting the best counseling options**\n\nI\u2019m analyzing the choices for counseling regarding vaping and kids. The best options seem to be II and III, which focus on discouraging vaping and recommending nicotine replacement therapy. IV and Statement I can't work since suggesting vaping is okay is misleading for adolescents. There's also the option of V for bupropion/varenicline, but that\u2019s more of a second-line choice. Overall, I\u2019ll go with J: II and III. I\u2019ll summarize that vaping should be discouraged, cessation encouraged, and NRT offered!",
            "reasoning_details": [
              {
                "type": "reasoning.summary",
                "summary": "**Choosing counseling options**\n\nI need to analyze statements to advise a mother about her son's vaping. Statement I suggests that vaping is better than cigarettes, which can be misleading for youth. Vaping is particularly harmful for adolescents and could increase their risk of nicotine dependence, so I think this one should be omitted. For Statement II, it seems like suggesting nicotine patches or gum could be a better direction to take, promoting a healthier approach. Let's keep evaluating!**Evaluating counseling statements**\n\nFor adolescents, nicotine replacement therapy (NRT) is an option for those who are dependent and trying to quit. It seems reasonable to encourage combining counseling with NRT, like using patches or gum even if it's off-label. Statement III mentions that while vaping's risks and benefits are clearer for adults, they aren't well understood for children. This pushes for a strong recommendation against vaping for adolescents, which aligns with health guidelines. Overall, I think this recommendation is appropriate!**Analyzing options for counseling**\n\nIn Statement IV, saying that vaping has clear benefits over cigarettes for children is clearly false. There\u2019s no solid evidence for this and vaping could lead to regular smoking. So, I think this statement should be dismissed. For Statement V, it raises questions about using bupropion and varenicline for adolescents. While varenicline is approved for ages 16 and up, and bupropion is sometimes used, the focus should still be on counseling as the first line of treatment for younger adolescents.**Re-evaluating counseling options**\n\nI want to recall standard guidance from the American Academy of Pediatrics, which suggests that pharmacotherapy can be considered for nicotine-dependent adolescents. Varenicline has shown some effectiveness in trials, but data is limited. Many guidelines recommend starting with behavioral counseling, then considering things like NRT or bupropion if that fails. Since her son is 16, initiating varenicline seems plausible. So it looks like I should go with statements II, III, and V. Now I should check which combinations work together!**Selecting the best counseling options**\n\nI\u2019m analyzing the choices for counseling regarding vaping and kids. The best options seem to be II and III, which focus on discouraging vaping and recommending nicotine replacement therapy. IV and Statement I can't work since suggesting vaping is okay is misleading for adolescents. There's also the option of V for bupropion/varenicline, but that\u2019s more of a second-line choice. Overall, I\u2019ll go with J: II and III. I\u2019ll summarize that vaping should be discouraged, cessation encouraged, and NRT offered!",
                "format": "openai-responses-v1",
                "index": 0
              },
              {
                "type": "reasoning.encrypted",
                "data": "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",
                "id": "rs_0ae55915038a5e35016909294a84f48190b37d929fd14aac74",
                "format": "openai-responses-v1",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "completed"
        }
      ],
      "created": 1762208073,
      "model": "openai/gpt-5-mini",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 1503,
        "prompt_tokens": 470,
        "total_tokens": 1973,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 1344,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.0031235,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 0.0001175,
          "upstream_inference_completions_cost": 0.003006
        }
      },
      "provider": "OpenAI"
    }
  },
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "openai/gpt-5-mini",
      "messages": [
        {
          "role": "user",
          "content": "The patient is a 47-year-old female who has been smoking cigarettes for many years. She has found vaping to be incredibly helpful for cutting down on nicotine. She recently became concerned that her 16-year-old adolescent son has started vaping. Her son still occasionally smokes cigarettes but mainly began vaping instead. The patient states: \u201cI\u2019ve found vaping to be a game changer in my smoking cessation journey, and I\u2019ve had a really positive experience with vapes.\u201d \n\nHow might you counsel her on her son\u2019s vaping? Select the options you would consider. \nI. Vaping is a better option for her son than cigarettes. It is ok for him to continue vaping, as long as he is trying to cut down. \nII. It would be good for her son to start using nicotine patches, gum, or lozenges instead of vaping. \nIII. Vaping\u2019s risks and benefits are well understood in adults, but not in children, so her son should not vape at all. \nIV. Vaping\u2019s risks and benefits remain poorly understood in children, but it has been shown vaping has clear benefits over cigarettes in children. \nV. Consider initiating bupropion and varenicline depending on her son\u2019s needs.\n\nAnswer Choices:\nA. I\nB. II\nC. III\nD. IV\nE. V\nF. I, II\nG. I, III\nH. I, IV\nI. I, V\nJ. II, III\nK. II, IV\nL. II, V\nM. III, IV\nN. III, V\nO. IV, V\nP. I, II, III\nQ. II, III, IV\nR. I, III, IV\nS. I, II, IV\nT. III, IV, V\nU. I, IV, V\nV. II, IV, V"
        }
      ],
      "reasoning_effort": "medium",
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E",
                  "F",
                  "G",
                  "H",
                  "I",
                  "J",
                  "K",
                  "L",
                  "M",
                  "N",
                  "O",
                  "P",
                  "Q",
                  "R",
                  "S",
                  "T",
                  "U",
                  "V"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762208073-ljJgbJHyPDYgsKOe0eKz",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\"answer\":\"J. Counsel that adolescents should not be vaping \u2014 the risks and benefits in youth are not well understood and vaping is not recommended for children. Encourage cessation with behavioral counseling and consider nicotine replacement therapy (patch/gum/lozenges) as a safer, evidence\u2011based alternative to ongoing vaping/smoking for a motivated, nicotine\u2011dependent teen. Pharmacotherapies like bupropion or varenicline are not first\u2011line for most adolescents and require specialist input.\",\"answer_letter\":\"J\"}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": "**Evaluating vaping counseling options**\n\nI need to evaluate options for counseling a mother about her son's vaping. The first statement suggests that vaping is a better alternative to cigarettes, but for adolescents, evidence shows that vaping carries risks and can lead to nicotine dependence. It\u2019s important to note that while switching to e-cigarettes might help adult smokers, it\u2019s not appropriate for youth. Thus, I believe recommending cessation of all tobacco use is the better approach. The second statement proposes nicotine patches or gum instead of vaping; I should analyze that next.**Analyzing nicotine replacement therapy for teens**\n\nWhen it comes to adolescents, I see that nicotine replacement therapy (NRT) can be an option for those motivated to quit. The FDA approves it for adults, but guidelines indicate that NRT can also be used for teens aged 18 and older, with some off-label use for younger youth. It's essential to start with behavioral counseling and consider pharmacotherapy for those with tobacco dependence, especially for those over 18. However, for a 16-year-old, it\u2019s important to focus on cessation counseling and consider FDA-approved options like NRT, bupropion, or varenicline while being cautious about off-label use.**Assessing vaping risks for youth**\n\nI\u2019m considering the statement about vaping\u2019s risks and benefits being well understood in adults but not in children. I think it's reasonable to counsel against vaping for adolescents, as nicotine negatively impacts their developing brains. While there might be some benefits for adult smokers, the overall idea that these aspects are well understood in adults might be a bit overstated. Regardless, when advising about youth, I would emphasize that vaping isn't recommended, making this statement mostly true.**Reviewing vaping statements**\n\nI'm looking at statement IV, which claims that vaping has clear benefits over cigarettes for children. I think that's likely false. There's no evidence supporting that vaping is better or safer for youth, making this statement inaccurate. \n\nNow, for statement V, it suggests considering bupropion and varenicline for adolescents. These options are backed by studies, such as a 2021 trial showing varenicline's effectiveness. In this case, it's reasonable to consider pharmacotherapy for smoking cessation in adolescents with nicotine dependence. I find options II, III, and V valid, but I need to check for overlaps among them.**Evaluating counseling options**\n\nI\u2019m looking at the mapping of statements II, III, and V. It appears that statement III is about counseling against vaping for adolescents, which I think is correct. It supports the recommendation to avoid vaping entirely. \n\nHowever, I realize that while II and V might sound reasonable, pharmacotherapy like bupropion and varenicline isn't typically recommended for those under 18. Hence, I\u2019m leaning toward saying the answer is J, which will emphasize not vaping, the use of evidence-based cessation methods, and that pharmacotherapy isn't first-line treatment for adolescents.",
            "reasoning_details": [
              {
                "type": "reasoning.summary",
                "summary": "**Evaluating vaping counseling options**\n\nI need to evaluate options for counseling a mother about her son's vaping. The first statement suggests that vaping is a better alternative to cigarettes, but for adolescents, evidence shows that vaping carries risks and can lead to nicotine dependence. It\u2019s important to note that while switching to e-cigarettes might help adult smokers, it\u2019s not appropriate for youth. Thus, I believe recommending cessation of all tobacco use is the better approach. The second statement proposes nicotine patches or gum instead of vaping; I should analyze that next.**Analyzing nicotine replacement therapy for teens**\n\nWhen it comes to adolescents, I see that nicotine replacement therapy (NRT) can be an option for those motivated to quit. The FDA approves it for adults, but guidelines indicate that NRT can also be used for teens aged 18 and older, with some off-label use for younger youth. It's essential to start with behavioral counseling and consider pharmacotherapy for those with tobacco dependence, especially for those over 18. However, for a 16-year-old, it\u2019s important to focus on cessation counseling and consider FDA-approved options like NRT, bupropion, or varenicline while being cautious about off-label use.**Assessing vaping risks for youth**\n\nI\u2019m considering the statement about vaping\u2019s risks and benefits being well understood in adults but not in children. I think it's reasonable to counsel against vaping for adolescents, as nicotine negatively impacts their developing brains. While there might be some benefits for adult smokers, the overall idea that these aspects are well understood in adults might be a bit overstated. Regardless, when advising about youth, I would emphasize that vaping isn't recommended, making this statement mostly true.**Reviewing vaping statements**\n\nI'm looking at statement IV, which claims that vaping has clear benefits over cigarettes for children. I think that's likely false. There's no evidence supporting that vaping is better or safer for youth, making this statement inaccurate. \n\nNow, for statement V, it suggests considering bupropion and varenicline for adolescents. These options are backed by studies, such as a 2021 trial showing varenicline's effectiveness. In this case, it's reasonable to consider pharmacotherapy for smoking cessation in adolescents with nicotine dependence. I find options II, III, and V valid, but I need to check for overlaps among them.**Evaluating counseling options**\n\nI\u2019m looking at the mapping of statements II, III, and V. It appears that statement III is about counseling against vaping for adolescents, which I think is correct. It supports the recommendation to avoid vaping entirely. \n\nHowever, I realize that while II and V might sound reasonable, pharmacotherapy like bupropion and varenicline isn't typically recommended for those under 18. Hence, I\u2019m leaning toward saying the answer is J, which will emphasize not vaping, the use of evidence-based cessation methods, and that pharmacotherapy isn't first-line treatment for adolescents.",
                "format": "openai-responses-v1",
                "index": 0
              },
              {
                "type": "reasoning.encrypted",
                "data": "gAAAAABpCSloADY0tHIrw5V5xOo0yLZ43kisWsHGg_T8_I0XUnm0eBZ3kb9wlbkc4Co3Y8J2pLty949bTPRg3iSFRr_y-feqyxikuEvforUzWOjaR7aq415mlTSp6lrSkOIXuDBCkZYdIQ9bmqTx6vr15MNyBNEbsiW3niV0ir1BzpBFz8juirZET1Mrw1qHvLBlQlDAlZ8NghiSC4kDRDt8ew9-AbOf_bnwendcn0wuM7_sJ3s731pUTM2MC8KH9aEzsQIQ2FVPsYqL4l_MVqanYc5LMpX2tCY6SoVHZeQjeZQs4DitLaB5C1HYCUdsFzl789Sr2opIFU5GwzpqJopJJpA8hhkRyWjhuzdP_ipIJJ0kr7vTdo3djF7CB0du9liAYcRNYQZ2ZZxd5t0IE8_f0BfSKL52dlvXq82nyykQQQTXX8TSS3nckaoBgxsPyJ5Qpt7oko10XyLt0i22-c0lYHZI32R-XcuJJSU-UiOeyHGX2tUMkgEoti7nla_AInjCSN8LrnYxJ24VHh5LydFMw4s4vShOr1EGp6yTM2Lhf9u5hhGCb5TCx1WIYo0T3-qS_-9J4PM95wjf3s1NfUsKaGLjBBaysyZzLPmELpTfr9vnKmvyq87fr9l17ZtNxREGgD2UFv7eG-Yvjg9t3si9XesvkpalzE3WC0HvrcFHEDxF8yDOWkLoOMsb5RpQMvNaCVXDqnhMTqiLNzarwkbNibq5zh5qHUDEhSrmG2sEVXFk1636ndPlIvmyVun3LIUm-9FXy1aQ-9-rutbUrTKw_g7fq1JJ96N_im3coh-u2n7u_L1PRojeh6-9uVVH7hHZy5ppW9GjurN-xOjMaWHw1beeJUgucN_7rI1uplPMiE1FbhAGV90Juuf5dXdBYMUZjNLRYahm-eJg6SmjjceQpYMcpXFD4LftvIK53aNX-6CUrkwH27SaUKZryX8ijVhwMapvxyQUBSlfTtR1PIKixajbyaUgMzLQcOWNraUEqH19pp-eZqtTcQS__-0hKsIO68Zs-TOZxKmFl8goykAWfH08s1BJJp9ZmDLKUIKUX1qb3K-2128srzBsOXMz3CWUOlYSg9cwDU_wOIyfidu6BNM2sQf-TSi8ZRHhPL_UtHpF3ktu92GGR0gcS8xKbVCUMGMRFdtcw5oajEKlzez_ODFXjph2WDtkvFjRzpYyLfwkngpwn7m0JaIEf8o0YwmECvZx6rWx-2nawRTVndNFUnBo0_uYrPxAF5EsDCOfJExq9NZW4Q55B31nG2EwiwoRzNmlqmYIWaWj4pz3JUeWxf6ctBB55pFCAH83ggt10AOloleDEsi5Ns8RLoauPDBo8UwZeggN-tI0YW3h-WrUu3dRJpIF9r2-d2i7FO6dIq1-U1GCjFqqYm4ZkySibbuGwc62G9T2cbpJtdlUxwNdBtFSYeYV_pqeL16JS5d929psNt1jTSAZfku6uc6ekWgh5thmGzxV8NmNh-FyONCUH3xnNkcb2dA6B1OGhqgETxJy7PqmJNgyxsqABO-x1YSsy1LrcnymbdgEGHpVj2lDGxanGx7UzQxz15d6THQkvHnXnubdz54mwZ2c8IEvtwAsrVQdofEImyXAxIvsyPtYcHtM7KIispk4OoQri5Z0rQbeCBhsZHoCQx69GzXu7Wyuwj2WQ1l5_ZJZ2rs4wmImSke48cxACve7TmUzM8aNckitJ3ndOf5YGKcjzn6QzdyohDK68ENSbQUPzB8E-Ag5qKLmt0BKjZEj9idTPRbN7QMv4lL3BFhjbxQxtk98dUjgk8Pb7fLlPRIKG3G3rNeH0wKUgNwqGDDLwmQWvgBA1X-zJOOPv4NlqsCQpalDnrQLwFCXq-WqX7xakYictPeqvUgU3d-cZLyt5CtMDTUKt3U_N4QscUZbTRIJOmhCACbmlSGUQK9_16pLyu1iM38-7-G2BhBoofnum2Saw3O9YPmuwR0dJNVKwFJ0A4xdEZJDp3RpVSjNnBKyBNH_-mAd2HCLsVetph47OQqfu4Zjbhs-5Mndd25nKFsInAg0aUS21N9mhJh4aNklTJQIxxf1-7pka22D1NXhV0MCQkSBLxRttKUqn9Yd37gb-UqKfezCukOWOemJ-miIBWiTGAtp4296OTBhDQVNrex3w14uv2WKwznEhTZBuHHlANdhKMR3gYT3SvDpdzLXr90W1p1S1BFGpokXPpzkzpulMDDe964MPfQfHQP5M7OgL_M8V2p2-d4Ku4Ko_5LN7jgzRS4aR0UHXGkxrIugFn25f_NigEXJmT-n2ozqWYSHfgc8kfTasYS-LLPmxYNysRTSycZFKjt5PeaQNdAQPUHX8TVwheXR64TLVNjGo2c4Z7apoReAX0wtyyi2WsjQUHTEHQjIH3PrZ3dsoH0Woa6wcnbbX6b0qsTXWl2aked4rVfBvk_WQo-rac1lO_YlLInTDY8OqfpSYKCmyPz-5wZEDsx2jcXAt-eadB5ka2XjMm22YHkr6ZQAeK3uLXvTCzJzw5VjHSqguKqPf3TcnaGC0FhTWyJoe1rLWggvHdstGfv2RvCoZjMYek5bRd-5GtjYVVn6w9lvPAm_xrbnuPguQwJMvhiZ3uN-Ptq4VWUkYXtdYsDaSjUSmodhnFMyA0vk2KciFZyIBilCdxr9jZRupeSHYBAAb-bVjpKApjIiwlhEbcZkh-GiFmBSIzPgADacmA6g16VqAAaLVtWYefymcza6w6cfHG0lMx1yu5TAngTZ7kXS9ZsXhX9QjK-bVSaNb-pdifbfzzgROmJoSKZhvYoAze8RLn8ekKlNMCrZeLekyjLjQVaP7woWXQmT_QK-6o8yojIiXehOoqVxPNhSkhJCzsk7CGsJLcplLVWWW_vBWlwSLKAqc29n4alkZpBQf2xW0cewYa6SH0oDLR8PpyP2guBR3ipcLU-WqBlKAGMDH9NNtZ47xb1c8nu1NVg31C8bmppKTPMt2C9xej6eg-gARUpjO7t31RZ1WVBcKaRPl95cpJOCu2S_E6hbWbKIx9snQsIV6CXkKBKIRFxtk-gajs-X9kq6Lkq9LDKXm4vU1WcTN179QUy3No1ecawLtz1Z6JA11zbQa25pYwBKj2OdspI7mI-C0otz3ikF_gJVtJ7WYvF2T5Bc05UnVQUSucZP62PLt_g1gHnHI-7gA-HNsG46XYhogFWqbh-crc8gwkr7ghOQ2n66lgW8TYQ6rV0m1vfiujpKeqokyQKPMWbtwbnzXtQ1sckFyxxw4-o8vBylHVtklIB7urh4EaUOc3g4xshuieYo2UOI3DRvYPZARns5gUH_uvkoHXyrGTQ_RMrZHO0lBBPur5PbYVrccrpILjLYx0lfBcNhzjFhIzM5V1hc4BP7NRk2IehyAmm7eXIEjAucpfhCTrG03MCe-IUuuwUsFLOmi-uxLiAkkWwojV2Q1n5bkQOp5PxHzwTtu7iTAkWoTRiWYERH4RKnqgM-YUQuvToO9LOt862Gx_uJudXgHjk3bA8goc3f9vNzfOq_sue4QUa89TvMUphwNzrN5K2FVUiaTHRuzyx3YH2F-OtpMrDuqcpXWobwkLZlgw36sd5-HgrMpxUitQl4htpOx9T8JcIRZiKYG2Di2sJVg_SVaYG9qTZAr775L94DXUTEtz-dxxk5N80EUU93RaeGoQ9d1nuHYzJhlEP31xnfoAXQNgWwe8j4ibTzMUSvJhA23u-kjSMC2u3mk_iI9GOX3a4QKa9DqQTqaUnkvs7deWOKQses1akxISvH3FDzG_NHkNj3_n_A5tR1jgzD78jPGkP8d-CFsTHZD6pFa-2EMvkZ9ZzjEyUX1rpwENdVp1AHjraa-9bO1suG9by0deAObYLhTU_GGhp2SVszRMajZR1GiAn7iuBGrR18kViv2bwutmE5huZvz_XdUU97RBFZtj2Z9RP-xmBUYcccECS0n0PLAKIuTC4hKWJ0QrDzsZUFIcrNH9DC4Je-QExCvqkjbvyIIGMmRzfes3e1VDsL4zpb6NXea1AXm-rTVefs33WL7TRzw43w7SObB9V2hhoOyifDpY5t9pnKmK9pst0uoUbrFihbuLY7t4Xpa6BV0YzfSbCuyVbpqrfENSUsuQHz0oGasQX8DvFXA4wKhHuY7kfIvcIi7VjlN5L8r0wYdBJdZEIDNdyg-Ggbz7KIHsoXQ1NH7_HKvld9oLRix8-VMlcFTm0ykDxZfj0U2_0DDdNQmvWSoYHcHQ9owK2HZPJZq2dyvNzQF0BiZGDjDQ5yLOtrHJIPzVbnvbHCAdca-kqHNZkSyl2H4UnLAStpADlVjquaF5NHkOknWQySWtfnPDJ8fj1JC1ormxRWsdRWe5GqWu2DLCQ69gbsfU1KcHGEnxKk4oU9HYPYpEjlXwBU0Nu83X6G1J9gO3KkC78WFqoTuny0hd559dz6TIPdThzcMrZhZgeZBNpNiR-et_CTa3VhH84oOH-ce2VTvmrQJ5ryeKIE3rQvGYjdzNzD-sZ-1czUTp1x5lv8O-YZgtRf7khIS03RYJOsPfNs9eDEp-SmYWYp_24wdKuh-43pc0CMwKC0KWtpE7xHwq8pbaF083z3FAmqB-Xzd7CBKw7AHt2Cdi9Df83OFMOSbmew-8kbTM3l_yFWHNvSX6bZdsA8zrTO6L7HvupLhWOhmQAaMmCdsADPOLnSplFgTN-i-lT6xfy8yWq7RPLqib0pWAOJ8iArgosgDRut1CUREUh6kBHY4ceOhgtTpiLrfFpcQ8u3mWg6Ss4RI8FV3Rz84y7d3B6oiLJHVBB46Qmi-fIYS6x6n8T1wJTwBDHPv7X-q5jdcbulBzX77ZmMDjbb_XAxjTILqOXP7VOCNnVOtKS1gEmCAenLJvfOOVw8cgq1_mFGzNBhIjaW5gZ2VyimCe3wAlaNqO_ZN9LvVH-ISg6DuEu7FQfM03jDTE2PZbFdnK6Xo8AQHTqG6o_PBs41RmcsTMzeMF7qVxeHwXrmqd3hnnpUPP5lKg2pe3brqM1_-pBIwQzXijXUB5pyk1jGWBAmQgdqqG6LYo2oLrTmSh3cazi4sfcKrWONwFoYaQ7270glPqpkAID9MCVj9HLOAScT4opPNI2sOd3JkxCKzOuXuTfnd86muLYw6WIryvWlCcBmaW9knQ0rL6awOhHyoUD2LkXDm-U1vIrTlgflneC9pmfX37MdueecZpwIHwtJNJ94B0UMO6SiSWCuC-x7mSWp2j7hmMY6czYQ0UPtQP9W7ta8f_qBBgUSyEC6aGdAVLeEgPz9ivoqys3dmm0DrHsCN62Jicf6PQu49YmzPKMMDDM2n1t8uzX77nk6Evoh3vqRWKjJcn4g-IuXWVFIruJLhCOEEfL_-XKkOQkeqE7uszOEYA11AAzvtSPeivEFUjXp1kZcVFCu0el6lMK5yPZXKwXm78UA_fYz4aoTXmDJfmsjvzptk6dn8MZTGN3F6rpGHrnyNrfqPF7Rpn4ljX31OZe_athR-q4qJoz-FByGIQVyrGwbn8pXFtWYQNbkeRg5rXgnbyywKiZpHhspAzRvYOU1Sk1xrCsKc2pVMkoyV0z0ZIRkP6Oj-o824gd00i2p7hO7fSPWB3emp3TR-iqF6Db0CDjG6vlRLpBgvlvYt2pOtGR0YNM3cm05OWMaQvJnF8-nSuHmp4l1cNNfoQO68MW1fOvbXn2oCGBrzMsWFbA7z5GpuuVRcsPcdhVHHdHp9f4c1Sp8UdBAGWrMWbdnKQXiMwevxz1bv4g2dN0iu7vPzjOcmM-MyZtdUs8P-GZsAmms02sWWV7v3gTs9_ukWnRvuvW2ZBJP0vRSvZgchqnSK3P3bb5ngHuhibFhqhSh4I0JtA1YW_5NtveuaEVixiI0OoyMIB_nv1AvYmP_Tq8MpBFRGXTL7JT99DB1Unh6tz2GWZeFQqsXZCXJ1G2aD96gPZrI6PzPTIUTiGjfngFSM4cJh5IxpSjbB-KiNlQU44CPPHOVxCyiUZNo1zqhNtSSzZrKKZQsQYpMj_nomgqcIYI_o6vqv7yWiI1ijU0UMrws8vhYp7NGf7En_yyAc7s1_nw6wCs9Leqik4CTb9LOLDI-DVXfoa0qUzkkFSobftiYgosZgeOUVdf1TjYRVigkEtKQr5VlAzpSoKrjnHnME1v3ElA789A8YcxH0kUb5vahui0pwIEodj5IILZcyfhseceWY7txSMPfF-bpVh0lRhfznhKFNXh5znptvrhCm5yjVB-0Jykaow0daIKT3SITvZ-Zy7Q6RctBBNeWmSasV_vO6I23oCHHf8nRi07bjwGsH-9pdFI6-BPFPNchJqBPAH7Hi1iZXsoNaQSMRVskX1Uc7QUXDU0a1Q_ZFiVP9vuGQ5bGSWZTm7oC3FlaSww-67FaM2jcsVTaIKtWURLGlxe1LuxluWBKjIAjnJvj0X3c-a02GmHTPPN8URlnz0LNXDycC3b-GTk3ksmTWcCYbRzpYdIYe8gT3dShfkwaCJFJAusPyeyZ7AGOOV8ZYLm33K0WCn4ybsYtOTgOOiqHU_-xC7v_SI8uM4saHRPCNohi87kVYMsGOicWHWDvLoi_2hCOQQLxYDr9lU8rbP13glCRSAQZUR1kJKfinieSyTHgMTxSkYV3EuKi9gYBrcmoHsVbmI0wNZQ4yEFxpM4YpljYnKNshth8dMdMrlwsjXwT4QrqlCU5dgNphfK5Y1bksFImzKW9-AQgj4jhJrxYeRN_QOyWRo5_zhpWyWM89qTr9HhL4eUgMJMASw-Vddy_AeWMRZ76SVlnRQvHqAqVNDX3Dm-ze4KHkHH6-cZHA6yBLmYctsTML6tRcEGQeuLKIo04hlXjP7WGklojF_8CWLlKKJiLbxoyNVSG385T1fNMsdbrxtTG9rOLNQnQGCz1XeENhazQ0gAzJEEiG84klP693wIiXjhY_LQqnSwWkuETm74N7XroQuUrGcYNymJj-SVsMt4bHyacYUSlB1f-w8v_J8faVK2xDZLaG_Ir-hQqpQZKnFyXsPv-yZR0fk1xJmidVxjiE1qqmqcEZ_XdIh7-nRqHp1fNiFTbK44tT13FUCM4ByurkWIuUZKNE_GF-8SFVlbJP7noWPAkGxYGxBcydQW4kHVyhO6yMShvv80sFbPj32UB_E4-X3PY8sX7EDvBXVf6sN0Lk5O0acgU73E2hjqXdFrSXky8AZhFRpwxvt2OWveL7B8W88Eba_gHcWO8zr2yNWLpIV6Nfl-TC0ImebxF1zMchYT7_oZilnQu4-Cfp2rQZpze524YIP60QbrrBY7Fxt9pLJdyi8KO9jCbAXYpQQp6xDdLKpgpG-WxYLDpWtAH46x2cANOM-r9pwUG_ilR7lefxmbMSJ3MBDpvQEzQOJ19hRhig57tG-2fE1AT1i1J49E7iguRgcybY4umg449b_BBTcTC1A5smJtb8477xfnQ09ZVr67HTtA4ovkRJZODWFHRd5r-O4xgqGPHcpIOhADhzNjNDLNQZ7mOeOt0kVIiIGOBCYif7o8HtwPJVH5YpYP0Ph8ko5Hio_g0ooXY9ii6TUxfOTBnbqGJxzjToaAbHjCltFqhYWFz9NbAnfRaazrpDZ6ocyipEQrXS9BzYCEmrRuE34CRw4X4E9Y_IpDOpirn1c02zSDjxKrzLj9UZ-mY1qZcd8-We6BmTSVk1UwTPs5mYcGUZvE7N0PwetqYC6019YYLwZIESZIdX0r4Moli4f5JlRgPT6WpE5gh7uCyEMhpN7NJghzVms-AoQ7cVYpH7yOkKHXDM3sTG0ely9NoYSNjI5GuVEFPS240FkCmnjszsiPyozYyk-lUjYRMdDWpHaDV61jiHkB8A64d3MPKrFS5K1rndXSqTDwkj5iao6CzmLJvTFcsY-yWwPFGnNuWnP8uNcMCXRyFnDVOMvkBRoiue6hV-BTV9iMwCxJ1vYAI-xeZN1PjVQwObSBxhnUJS7tJxhx8nfPZLhlAh3y8fbgbtCZXem2D1az5eO5kMgo-MysLm8gzDHicS5svVzMQOtqCiA_UdhbRacmN08CEGgY7OTIYtN3YG8NX5wN-pAD63SMTtFTjr4JgvkZ_fmrzgYKet3zufKalB1GD0gCNK9OGL9G_-yLqS9cmRIeD_QVsjaaqw0HtTj7JboQzk_XAi1eS8sk-Ws-yiL9jJSh5r21Y0B7e1NOIb-ckg7NbO_WmiU2TxLVVPapZwQONnIBY3ZiNtbdWpPhofHimqXIKEDHdrvr_LGdQYtETil8PEZC0S-9KWq-u6igDN5zRJ0T4hqhPBxsSkd5bpvsj1zmySRdebCdiJc5MtAVtRR1Le2E2JfbIJMy2iMMeHc-CN8VMEGljJEVtOkDCBSvXYMzE1j_-sRwN9QVQNHQyxHZPa5AdA3jKTJCob7zMR25k2C3srz9Fh78OxYXdZ1C-3YTjs6YN1IwmaxjrbM3S-4oWFt0Ge57QOvX7fKc3Ba7oclraLE3dFP8QCJdoV3mc6lu2judooUUpZ3t6aJBE7RRf3vQhNgvh7qNog8kyR7I5nN-PHLaQRn1MEvIMyPE-jXbFYMrZx70p1A9AIJQVYdJHull3U3vZtxEm6aYUTO5c6B0gCNSBHYSB5A1lOtv-KPx6Tk4NUDAHZgInn9PQc8eW-6QMouj7ttgdf187gsq5jHsA1Smg0SkczBBdGx3fjcJCP6YeRThSIenHxAnCU_j0KpnI9HhXAGCSEvo5MRHKD9JyL1uxS1luZFvkMMzEAQ4ugL2t1CwzHAsbazU0LH7oEQjik2J60UYXdaePZClI7qEqMmvwEtoYCmJepnGXfTkmgaNQ6k-9bwuK1hIFu7qGhz7VKIe7CbnNohC-tr4dPQ4Nhrmxx_iETmjNh_3BrCD8jA7dAZltl3SkO5b1cLMy8hTfRdNV_EfSplRtEg8XMorazIUnriDud832LSQExAT2sX20zsQc-SlWBMsOUWIXNfIyitPud-5qh9qc7kbx9ENydHjlDTpOMNC2dJQoHe_QcBQh57D6S8eRPeBFTRUkttYcNIT48kUmoXl2k4tuECOGpYkgK0FJsgSyTIpPxHdTuDEEzPPLfvKnrhAcFGePeItDvgxdxk4wWxmylOXXN1u4MNxAR-w7HZOre23T1v8n8_PAM3zkcAK3GbHrNyJQq5vgNCHo_aePGth9M-EWtZLm75WfW-9edetT8Rc0DQtPdvht8XPjRhepoQVbJy_t8jg2SmQkECJrjdPBGzxxj89_596wG-scXs0I3oenai1zFar9e1yJi6kmJ698lsq0C-VH0j-8M8ttQV0xaTTShf0LOmDL_pS4S-Ur5jSR_k8ne-PU6bA-25egAjXcV5vtP79Y6ri9j7E38_ZCzGUsFO9ytyUkHjfOYIsLKPutI7DLYNcRpXVQEcusWbjsdPQIqlsSnq7PuWCCrUO0rV_FUkZNB3CnCmO87xUp_ph4afh5ocbM4BCcewkcIcz-rMiuPuWz_uJDEgmzNehnd_b89EQ39Pmw6LI3d5XZzxreJJk_cJjw_eP6zUii47UK-u1muAG0B3fNhkGBL-i5DmqVoW3Bo70Hpcrk-N1acJkmlcRcyTvCpL-x1dBc6lkZyjavGya_osqYkrNCVa8W8KUNKv_J68VMnBb9R1BhyY8ZHh_WNN3IIOZUf04bzWSihjHPECwHmOcJzsRZkJ1EjcobRt8Tl4lPY9rt-3G8NaI0QZ6ZuAWWDbp68TDtK46p8Ck3N_IksKXqHq2Dl5-w6xIggXEBcAsuL0Qs9BC1QXHoCVAU3mDNOIkZfznGOBiIZ45r0FYb2LNC_7J0nPWVBhK4UnUfdQ9TV03y3x43N4CDeIMqDKL72L4QJ4GRCZXIOwgr0MX91I3C5ARHWmMhpQEm-HhpcOyd3MSSHhwJM8k0pAieXfcbNNiFK8lN5ZDn-NXZjIM2baUJH76gGIcnCenvDAMwcha2-g7hBcPsb0Ar_GmZ8-XMjV3IKThHWwADa-OETue6WYmIGdCKB3qghuq8qLrpPeZ5bvtnLGExAFL7r0grfjetSUmvHe1mETi1mVS1A6bv0_3XaZas9pklNDHnWdee1r8SOjV9klsn8mceNkFUWAcOoiiVyUOl9mAAnQll0U9LLqC4-G_N9Ci7VUhdEza3JUGwOzFTvu_0Xh34ldQ7UYbz5ImLsFnMdD9YIkhJyLAX7CjAp99WKrh5j3HeISpRQA6tyBTnjmrxkwF90nuBi3F8OABo_JDAQqG4PqoGiZmczz4aaEAhhgCFAH-LurO_25q8FnY9lqjuTCz3v4GWR38bDkgWKIJtcM8PGEVqn3u54BiKA8aQbj5FLtiHuMevjOF1yjJnhR-k6biXVyQJhpQcspT-ftmj68Q0pi9_JSW5GWj0gXzhBrdODApyO7yoTGQa2Opwe3C5rR56SmfkHiuctUEq2msEjWTKguwXpfRjlYTs_wyCr697XZ5n7qVm3vHKRmXIvZDXeJD8rT6NYX1QCg4JM7EvxJrxagI0dJmf_iCPitrioPvQdBV7MBQDnN-Cm3bhw_wFDHH_78x4GN9IGv752kqswtkicyoHqI09wKhEXbc3YBed7U47zY1_7NjECFDYI7bWISajlyJBjck-pNHtSp3HPn6x7DN6NEGftzYzYyqcRgc6xmMwVqNcD58-vue0F4xUOpsAHqUNsw15m0McDJ8cbEojMuD2zxHg4cMJfGez9nDxBG1a2Jr4_5HnOa4M5N0AgLEIu3HcxRqhwu_IK5udFkJQFARetFEuch4W44BQ6R3AWr0cl6D70MeSz2VqiAUZXSLsDpoDY-OUyiO2xKiQtuhroIFkCAhPHgW7LoVRN7jHMIPoidwWzsjMgS3wgZJmVkbZXq9LiUoq6xgG3gL6gAdfXDWGZeNeNrG1WjDKTjKDgMkT21wOO_liG-acw2bixROK6goMpIoCkS5x1-00pivTNnQG1vDoAs23FirsW88ONMIx6n_pU08jtbkuGyeUOJQyvL8ruNgcXVsTWBN6hBRBofDNmkwZRQfqUrXc8hwRnetjQU0PI3SgIFBnVcZDV0YyNn2ja8RxaJL3nbjwFo39sGAYiVJMxYAcvEFQYOcxslyf-4-E9iLCX4lVjJdASLQxXTIy1cOqOd_6T0ElW5WvS9jLUiprUxDMIKl0eNODdIscSBVJGLLlwwxgFlA-ZyQdj6bdgmampOAfll7GdCtPYpBsiY5GQnWK3IcKbF-d0OWx0BEz1xOUJh9-x5EXA8PYqtayzcOJB2kBMTExugH5QgcCeuVe7fFPIi3wsUw_qcKQuTf02Z9GAas9ChbaGxqDIysxNruzxJmqTvZFGr5nk5o6cfK5nYAQE0H7YR0rya3rp73Vf7WQ82R8Lmvy43WhnbOJqmskSYuRAmuQ3E4ZJaDdwHaHtmP_o2zfJJa5EuEDKxDoxmMWVHvHbfYVckuTpjJ4PH9Sas1FORdi7HAefzqhdcycrDaCjaXkAjBgAy2zbE3wDLI7_iNF5HU2vfI_xpuCxWHzYwYWjsT_dbTpyxQSOqf0fItyzV6AGORjsUytVvdxhYuGsXzM9_ae7CtSDD53m83NKx4FiPSZ3LGS7URiDMdXENKEdF_sACJ0u8kdzC8vgfzhhqryqLMRkvcv-mnJ4iL-O4KPdrWXFNLz37Zy3z8Ta1hiW7oNa-tD-expPUOdyPrbhfXz0QFYf2heFIlrSJfvVXiRfvwMH59A17ohrInZL-J-7_63StrVn28quspjehs0KSJWWRJlYnSzqGyLF97C3OSoZZ_W5g_P-r4UrbpxzwedmMflvzj17VzMGocFh6XME7_VuAguZ1UHaASumjJBHijpmjkU8wuyjvRh-JJRWxI97XigRr7mfEKnLA4oH6SBhYYcc7pkxae2ATOdp-7r5-aYHSMqjiE=",
                "id": "rs_0dae1748d6f4eebe016909294aff488190b2fcc666a2474575",
                "format": "openai-responses-v1",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "completed"
        }
      ],
      "created": 1762208073,
      "model": "openai/gpt-5-mini",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 1840,
        "prompt_tokens": 470,
        "total_tokens": 2310,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 1728,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.0037975,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 0.0001175,
          "upstream_inference_completions_cost": 0.00368
        }
      },
      "provider": "OpenAI"
    }
  },
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "openai/gpt-5-mini",
      "messages": [
        {
          "role": "user",
          "content": "The patient is a 47-year-old female who has been smoking cigarettes for many years. She has found vaping to be incredibly helpful for cutting down on nicotine. She recently became concerned that her 16-year-old adolescent son has started vaping. Her son still occasionally smokes cigarettes but mainly began vaping instead. The patient states: \u201cI\u2019ve found vaping to be a game changer in my smoking cessation journey, and I\u2019ve had a really positive experience with vapes.\u201d \n\nHow might you counsel her on her son\u2019s vaping? Select the options you would consider. \nI. Vaping is a better option for her son than cigarettes. It is ok for him to continue vaping, as long as he is trying to cut down. \nII. It would be good for her son to start using nicotine patches, gum, or lozenges instead of vaping. \nIII. Vaping\u2019s risks and benefits are well understood in adults, but not in children, so her son should not vape at all. \nIV. Vaping\u2019s risks and benefits remain poorly understood in children, but it has been shown vaping has clear benefits over cigarettes in children. \nV. Consider initiating bupropion and varenicline depending on her son\u2019s needs.\n\nAnswer Choices:\nA. I\nB. II\nC. III\nD. IV\nE. V\nF. I, II\nG. I, III\nH. I, IV\nI. I, V\nJ. II, III\nK. II, IV\nL. II, V\nM. III, IV\nN. III, V\nO. IV, V\nP. I, II, III\nQ. II, III, IV\nR. I, III, IV\nS. I, II, IV\nT. III, IV, V\nU. I, IV, V\nV. II, IV, V"
        }
      ],
      "reasoning_effort": "medium",
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E",
                  "F",
                  "G",
                  "H",
                  "I",
                  "J",
                  "K",
                  "L",
                  "M",
                  "N",
                  "O",
                  "P",
                  "Q",
                  "R",
                  "S",
                  "T",
                  "U",
                  "V"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762208073-7WoB9B4QRbYBhaoyeDxh",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\"answer\":\"Best counseling would be to discourage any vaping in adolescents and offer proven cessation aids such as nicotine replacement therapy rather than e\u2011cigarettes. Therefore choose II and III. Rationale: youth nicotine exposure harms the developing brain and vaping is not recommended for adolescents; evidence on harms/benefits in young people is limited, so they should not vape. For cessation, behavioral counseling plus NRT (patch/gum/lozenges) is appropriate; bupropion/varenicline are not routinely recommended for adolescents.\",\"answer_letter\":\"J\"}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": "**Assessing vaping counseling**\n\nI think the statement about \"risks and benefits are well understood in adults, but not in children\" might be a bit off. Adult evidence suggests vaping can help smokers quit and is likely less harmful than cigarettes, but the long-term effects are still unknown. Overall, the crucial advice should be to discourage any vaping in adolescents. The option phrasing should emphasize not to vape, so III could work while IV is incorrect. Lastly, option V could suggest considering bupropion or varenicline based on her son's needs.**Exploring adolescent pharmacotherapy**\n\nI'm looking into pharmacotherapy for adolescent nicotine dependence. So, I wonder if varenicline and bupropion have been studied in this age group. It seems varenicline is approved for adults over 18, but in the U.S., it was expanded to allow those 16 and up. For 16-17 year-olds, it might be used off-label, and there\u2019s some evidence for its effectiveness in clinical trials. Current guidance suggests behavioral interventions as first-line treatment, and while bupropion is sometimes recommended, it's only approved for adults as a smoking cessation aid.**Evaluating counseling options**\n\nI'm assessing the options regarding bupropion and varenicline for adolescents, considering the need for specialist input in certain situations. It seems that the best answers may be II and III, particularly when counseling a mother about her son's vaping. The key messages should stress that tobacco and nicotine use in adolescents isn't safe. For cessation, I'd recommend behavioral counseling and consider FDA-approved options like NRT. Bupropion and varenicline might be second-line options. So, I think II and V are viable choices, with III aligning with the advice to discourage vaping.**Determining best options**\n\nIn looking at the best options for counseling, I think II (NRT) and III (discourage vaping) should definitely be included. V could also work, considering bupropion and varenicline based on individual needs. However, varenicline is typically not approved for those under 18, and the same applies to bupropion. CDC guidance suggests behavioral counseling and nicotine replacement for youths wanting to quit e-cigarettes. It seems the best selections would be II, III, and possibly V if they align. Let\u2019s check for options that include all three.**Choosing the right counseling options**\n\nIt looks like I need to figure out which options to select regarding counseling on vaping. The mother believes vaping helps her son quit smoking, but I need to emphasize that vaping isn\u2019t safe for adolescents. While II (NRT) is good, and III aligns with the cautionary stance about vaping, option V regarding bupropion and varenicline isn't typically recommended for teens. So, it seems best to choose II and III, which is option J. I'll prepare to answer with that choice and provide a brief rationale about discouraging vaping and stressing behavioral interventions.",
            "reasoning_details": [
              {
                "type": "reasoning.summary",
                "summary": "**Assessing vaping counseling**\n\nI think the statement about \"risks and benefits are well understood in adults, but not in children\" might be a bit off. Adult evidence suggests vaping can help smokers quit and is likely less harmful than cigarettes, but the long-term effects are still unknown. Overall, the crucial advice should be to discourage any vaping in adolescents. The option phrasing should emphasize not to vape, so III could work while IV is incorrect. Lastly, option V could suggest considering bupropion or varenicline based on her son's needs.**Exploring adolescent pharmacotherapy**\n\nI'm looking into pharmacotherapy for adolescent nicotine dependence. So, I wonder if varenicline and bupropion have been studied in this age group. It seems varenicline is approved for adults over 18, but in the U.S., it was expanded to allow those 16 and up. For 16-17 year-olds, it might be used off-label, and there\u2019s some evidence for its effectiveness in clinical trials. Current guidance suggests behavioral interventions as first-line treatment, and while bupropion is sometimes recommended, it's only approved for adults as a smoking cessation aid.**Evaluating counseling options**\n\nI'm assessing the options regarding bupropion and varenicline for adolescents, considering the need for specialist input in certain situations. It seems that the best answers may be II and III, particularly when counseling a mother about her son's vaping. The key messages should stress that tobacco and nicotine use in adolescents isn't safe. For cessation, I'd recommend behavioral counseling and consider FDA-approved options like NRT. Bupropion and varenicline might be second-line options. So, I think II and V are viable choices, with III aligning with the advice to discourage vaping.**Determining best options**\n\nIn looking at the best options for counseling, I think II (NRT) and III (discourage vaping) should definitely be included. V could also work, considering bupropion and varenicline based on individual needs. However, varenicline is typically not approved for those under 18, and the same applies to bupropion. CDC guidance suggests behavioral counseling and nicotine replacement for youths wanting to quit e-cigarettes. It seems the best selections would be II, III, and possibly V if they align. Let\u2019s check for options that include all three.**Choosing the right counseling options**\n\nIt looks like I need to figure out which options to select regarding counseling on vaping. The mother believes vaping helps her son quit smoking, but I need to emphasize that vaping isn\u2019t safe for adolescents. While II (NRT) is good, and III aligns with the cautionary stance about vaping, option V regarding bupropion and varenicline isn't typically recommended for teens. So, it seems best to choose II and III, which is option J. I'll prepare to answer with that choice and provide a brief rationale about discouraging vaping and stressing behavioral interventions.",
                "format": "openai-responses-v1",
                "index": 0
              },
              {
                "type": "reasoning.encrypted",
                "data": "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",
                "id": "rs_0cd9e7011df5364d016909294a6a748194becec0809f2602fa",
                "format": "openai-responses-v1",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "completed"
        }
      ],
      "created": 1762208073,
      "model": "openai/gpt-5-mini",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 1530,
        "prompt_tokens": 470,
        "total_tokens": 2000,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 1408,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.0031775,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 0.0001175,
          "upstream_inference_completions_cost": 0.00306
        }
      },
      "provider": "OpenAI"
    }
  }
]